No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - One Health Group reported an 11% rise in full-year revenue to 31.6m on Monday, with adjusted EBITDA up 28% to 2.6m and ahead of previous market expectations.
The AIM-traded, NHS-funded surgical procedures provider said new patient referrals rose 11% to 18,931, consultations increased 20% to 50,774 and surgical procedures grew 15% to 8,113.
It proposed a total dividend of 6.3p, up 2%, and said it remained well funded to support organic growth and the roll-out of its first surgical hub, with construction underway and capacity expected in early 2027/28.
Chief executive Adam Binns said One Health was "well positioned to support the increasing demands of NHS commissioners and NHS patients through the delivery of more local healthcare, free at the point of use."
At 1248 BST, shares in One Health Group were up 3.51% at 251p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.